My only allowed post today at the other board was removed

New Post Public Reply Private Reply Replies (2) Message Board
BruceLake
752
My only allowed post today at the other board was removed due to it being a personal attack. What do they expect, that we extend personal compliments to management and all of their accomplices?

As I said to a friend today, I had to sell before the end of the year for tax reasons. I still hold some shares in another account, meaning that I'm officially allowed to bitch about the company and at the same time hope for a miracle.

Here is the deleted post:

Here is my one post of the day so I apologize in advance if it’s lengthy.

With regards to the previous R/S below is an email that I sent to Mr. Kenneth Koch back in April of this year. Obviously in the interim nothing has changed except giving us more reason to be upset, and justification for the added adjectives hurled to the pigs and criminals at management and those who support them. Yes, those who support them, are complicit, and are turning a blind eye to the scam that is going on, all for the almighty dollar! Yes, that includes Koch, Rubin, Sims, V-Stock Transfer, and let us not forget, all the “research facilities” that are supposedly conducting the “science” and profiting from those shareholders that have been victimized by the fraud that has been and continues to be committed.

We have every right to be pissed off. Nobody likes to be robbed. Thieves can end up in jail for stealing a chocolate bar, meanwhile for these vultures it’s business as usual. Feel free to forward this to everybody in management and anybody else that you can think of. Here are their emails:
KRKoch@mintz.com
mordechai.bignitz@owcpharma.com
stanley.hirsch@owcpharma.com
Sigal.Russo@owcpharma.com
alon.sinai@owcpharma.com
yehuda.baruch@owcpharma.com
jeffrey@jeffreyfriedland.com
rrubin@parkavenuegroup.us

For the sake of transparency, I’m glad that I held most of my shares until yesterday’s Record Date. Today I sold all of my shares in one of my accounts, but I am still entitled to vote. Not sure if it will make any difference but I plan to vote NO just as I did the last time. You may ask why sell now? For me the reason is very simple. My shares are worth much more dead than alive! The capital loss will offset my income tax on other significant capital gains.

Having said all of the above, it is my sincere wish that there is a miracle rebound so that many of you can recoup some of your losses. Given my record with timing that could very well happen.

Here is an email that was sent to OWCP’s lawyer and then no doubt forwarded to management. It’s already been shared with some of you. Remember my one-post limit, so I won’t be able to reply.

Good luck!

Quote:
Dear Mr. Kenneth Koch,

I am a shareholder of OWC Pharmaceutical Research Corp., trading as OWCP on the OTC exchange.

My understanding is that you and your firm are providing legal services to the company. I would assume that you are duly licensed to practice law. I say this with all due respect because for many years OWC Pharma engaged the services of a disbarred lawyer by the name of Richard Rubin. Mr. Rubin was referred to me by the company’s representatives Amir Uziel and Jeff Smurlick. I required the services of Mr. Rubin, specifically an opinion letter, in order to remove the restrictive legend from shares that I purchased as part of the company’s efforts in 2017 to raise funds. The shares were held by the company’s transfer agent, V-Stock Transfer. Transferring the shares to my trading account after the 6 month restrictive period proved to be impossible. This was mostly due to the added restrictions that V-Stock Transfer imposed, and partly due to the fact my broker RBC Investing, wasn’t about to compromise how they conduct their business. In order to facilitate the transfer, the afore-mentioned disbarred lawyer also had to provide an opinion letter to RBC. As it turns out this took almost a year to resolve, and not after the intervention of a consumer advocate. Meanwhile the company did absolutely nothing to help and facilitate the transfer, even though they promised that they would.

The SEC fraud case against Jeffrey Friedland made reference to a “disbarred lawyer”. I put two and two together and after some effort I was able to confirm that Richard Rubin had indeed been disbarred since 1995. On March 9, 2018 I sent an email (found below) to Yossi Dagan, the previous CFO advising him about my findings. Mr. Dagan acted surprised that all these years the company had been dealing with a disbarred lawyer. In a telephone conversation he said not to worry because they were now in the process of engaging the services of your law firm. When confronted, their standard reply to any of the well known and documented failures of the past, were to suggest that they were somehow also victims. They also went out of their way to say that the high caliber of the new management would not repeat the mistakes made in the past. Of course, Mr. Dagan glossed over the fact that some of the past management, including Mordechai Bignitz and Alon Sinai, had been in fact a constant since the inception of the company.

Speaking of management, apparently nothing has changed! From our vantage point as shareholders, it looks like the company has digressed with even more egregious mistakes being committed. Just over a year ago at the Wall Street Conference, Dr. Stanley Hirsch promised that given their new management team and considering what the company had already achieved so far, they would be “building massive .value for its shareholders”. He also went on to say that the company was looking for needed capital to further their research. What Dr. Hirsch should have said is that they were about to venture into a mission that was guaranteed to destroy shareholder value. As they say actions speak louder than words, and sometimes the best deal that one can make is the one that they don’t consummate. The $5 million loan agreement with Discovery guaranteed that they were headed to an ill advised mission that would keep on eroding any shareholder value that might have been left. One did not have to be a genius to arrive at this conclusion. To put it mildly, the agreement was toxic.

In an email that I sent to Yossi Dagan on May 10, 2018, I pointed out not only several errors in the loan agreement, but I also highlighted the “triggering events” within the agreement. Did anybody bother to read it? The most obvious triggering event that they should have addressed was Dr. Baruch and the possible legal issues that he might have to face. Sure enough, that’s exactly what came to pass. As a result, the company now was forced to pay Discovery bonus shares at a much greater discount. Anyone with any degree of competence should have picked up on this and dealt with it before the agreement was executed.

As a result of mismanagement, the company is now asking shareholders to support their proposal to implement a reverse split at some point before the end of the year, on terms yet to be defined but within a range of 1:2 to 1:500. Yes, Dr. Hirsch, is indeed asking shareholders to issue the company a blank cheque. The vast majority of shareholders have lost confidence in the current management group. History tells us that whatever it is that they will do, it will not be in the best interests of its long-suffering loyal shareholders. Their lack of communication with shareholders is so quiet that it is deafening. With regards to the proposed R/S the company wasted $7,500 for solicitation purposes to engage the services of a company and individual that was as clueless as a doorknob, who knows nothing about the company. In an effort to enhance their chances of getting approval to their R/S proposal the company also cooked up an ESOP that was backdated to February 5, 2019, strategically dated the day before the shareholders of record date of February 6, 2019. But it was not announced until some 5 weeks later in March. Not only was this a devious attempt at stacking the deck in their favour, it also brings into question legality and ethical issues.

Suffice it to say that the above sentiments are shared by an overwhelming number of shareholders. I would respectfully request that management re-thinks what their next moves are going to be. A significant shareholder made the comment that OWC has already fumbled the ball a few too many times in the end-zone. If not strictly illegal, they are certainly walking an ethical tightrope. All that one needs to do is to look at the circus atmosphere and the fraudulent pump and dump activity by the company’s past advisors. They may try to deny this all they want, but there should be zero doubt that management has been complicit to what was going on, or they were being grossly negligent, naive, or both. This is the history and legacy of the company. Going forward I trust that they will be very careful on how they proceed.

This email is being sent with the support of numerous shareholders that like me are heavily invested in the company and that are just as concerned with the direction the company is taking, and with their utter disdain towards us. The management has shown no respect for the fact that we the shareholders are the foundation of the company. I am directing this email to you because it seems the company has now made the decision to stop communicating with its shareholders, even when all we want to do is help. I kindly ask that you bring this email to management’s attention. Ultimately, we all want the company to succeed, to prove us wrong and to make us proud.

Respectfully,

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 1

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 1

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 0

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Midea's SpaceMaster Oven: Revolutionizing Home Pizza

Updated Category News Views 2

Oven Culture: Beyond Simple Baking When it comes to the kitchen, we're always promised more than we get. You know the spiel: the heart of the home, a place for traditions. But honestly? Most ovens are about as exciting as watching paint dry. Often too cramped, uneven, and a pain in the backside to preheat. But then, out of the burning blue, Midea comes along with their...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 0

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 1

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 2

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 2

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 0

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading

Top 5 Most Recently Viewed Articles

Wabtec Corporation Welcomes Juan Perez to Board of Directors

Updated Category News Views 313

Wabtec Corporation Welcomes New Board Member Juan Perez Wabtec Corporation (NYSE: WAB) has recently shared exciting news regarding a significant addition to its Board of Directors. The company announced that Juan Perez has been appointed to the board, effective at the end of January 2025. In addition to his appointment, Perez will also be up for election during Wabtec’s...

Continue Reading
Venafi Enhances Machine Identity Security for Tomorrow's Needs

Updated Category News Views 41

Venafi took a swing at the enterprise security game back in 2024, launching its latest set of capabilities just when businesses were scrambling to adapt to a multi-cloud landscape and gearing up for quantum threats on the horizon. Traders had their eyes peeled on these developments because, let’s face it, cybersecurity isn't just a tech gimmick anymore; it's become the...

Continue Reading
Cyolo Enhances Security with New AI Features in Cyolo PRO

Updated Category News Views 64

Transforming Remote Access with Advanced AI Technology Cyolo has made a remarkable leap forward in secure remote access with the rollout of Cyolo PRO (Privileged Remote Operations). This cutting-edge solution features Intelligent Supervision for Operational Technology (OT), harnessing the power of Artificial Intelligence (AI) to redefine how organizations handle remote...

Continue Reading
Cellebrite Releases Its Annual Report for 2024, Highlights Key Insights

Updated Category News Views 400

Cellebrite Completes Filing of 2024 Annual Report Cellebrite, a renowned name in digital investigative solutions, has officially filed its Annual Report on Form 20-F for the fiscal year ending on December 31, 2024. This significant move marks another step in the company’s commitment to transparency and accountability, aligning with its mission to facilitate justice and...

Continue Reading
Boeing Airplane Deliveries Surge Amidst Market Challenges

Updated Category News Views 170

Boeing's Delivery Momentum and Market Outlook Boeing Company (NYSE: BA) is currently experiencing notable momentum within its 737 and 787 programs during July. Despite the traditional seasonal slowdowns that occur this time of year, Boeing has adeptly maneuvered through the challenges, illustrating a robust production pathway. Analyst Insights on Boeing's Performance...

Continue Reading